Re: Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy - Response

被引：0
|
作者：
Vansteenkiste, JF [1 ]
Colowick, AB
机构：
[1] Univ Hosp Gasthuisberg, Resp Oncol Unit Pulmonol, B-3000 Louvain, Belgium
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2003年 / 95卷 / 10期
关键词：
D O I：
10.1093/jnci/95.10.762
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：762 / 763
页数：2
相关论文
共 50 条
  • [21] Randomized, double-blind, placebo-controlled study of darbepoetin alfa every 3 weeks for the treatment of chemotherapy-induced anemia
    Taylor, K
    Ganly, P
    Charu, V
    DiBenedetto, J
    Kracht, K
    Rossi, G
    Hernandez, E
    BLOOD, 2005, 106 (11) : 992A - 993A
  • [22] A Randomized, Double-Blind, Placebo-Controlled, Phase III Noninferiority Study of the Long-Term Safety and Efficacy of Darbepoetin Alfa for Chemotherapy-Induced Anemia in Patients With Advanced NSCLC
    Gascon, Pere
    Nagarkar, Rajnish
    Smakal, Martin
    Syrigos, Konstantinos N.
    Barrios, Carlos H.
    Cardenas Sanchez, Jesus
    Zhang, Li
    Henry, David H.
    Gordon, David
    Hirsh, Vera
    Kubota, Kaoru
    Orlov, Sergey
    Thomas, Gary
    Steinmetz, Tilman
    Kang, Jin-Hyoung
    Tomita, Dianne K.
    Fleishman, Alexander N.
    Park, Joseph K.
    Brandao, Cisio De Oliveira
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (02) : 190 - 202
  • [23] A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial)
    Giles, FJ
    Miller, CB
    Hurd, DD
    Wingard, JR
    Fleming, TR
    Sonis, ST
    Bradford, WZ
    Pulliam, JG
    Anaissie, EJ
    Beveridge, RA
    Brunvand, MM
    Martin, PJ
    LEUKEMIA & LYMPHOMA, 2003, 44 (07) : 1165 - 1172
  • [24] Efficacy and safety analysis of epoetin alfa in patients with small-cell lung cancer: A randomized, double-blind, placebo-controlled trial
    Grote, T
    Yeilding, AL
    Castillo, R
    Butler, D
    Fishkin, E
    Henry, DH
    DeLeo, M
    Fink, K
    Sullivan, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9377 - 9386
  • [25] Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia
    Hernandez, Enrique
    Ganly, Peter
    Charu, Veena
    DiBenedetto, Joseph
    Tomita, Dianne
    Lillie, Tom
    Taylor, Kerry
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (09) : 2109 - 2120
  • [26] Re: Efficacy of Everolimus in Advanced Renal Cell Carcinoma: A Double-Blind, Randomized, Placebo-Controlled Phase III Trial
    Culp, Stephen H.
    Wood, Christopher G.
    EUROPEAN UROLOGY, 2009, 55 (06) : 1484 - 1485
  • [27] Phase III study of apatinib in advanced gastric cancer: A randomized, double-blind, placebo-controlled trial.
    Qin, Shukui
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [28] Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting
    Hengge, UR
    Stocks, K
    Wiehler, H
    Faulkner, S
    Esser, S
    Lorenz, C
    Jentzen, W
    Hengge, D
    Goos, M
    Dudley, RE
    Gham, GR
    AIDS, 2003, 17 (05) : 699 - 710
  • [29] Donepezil for cancer fatigue: A double-blind, randomized, placebo-controlled trial
    Bruera, Eduardo
    El Osta, Badi
    Valero, Vicente
    Driver, Larry C.
    Pei, Be-Lian
    Shen, Loren
    Poulter, Valerie A.
    Palmer, J. Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (23) : 3475 - 3481
  • [30] An International, Randomized, Double-blind, Placebo-controlled, Phase III Trial of Pregabalin Monotherapy in Treatment of Patients with Fibromyalgia
    Pauer, Lynne
    Winkelmann, Andreas
    Arsenault, Pierre
    Jespersen, Anders
    Whelan, Laurence
    Atkinson, Gary
    Leon, Teresa
    Zeiher, Bernhardt
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (12) : 2643 - 2652
12345